Medical Expert - Glenn J. Lesser, MD

Area of Expertise: Cancer - Brain
Area of Expertise: Cancer - Pain Management
Area of Expertise: Cancer - Symptom Management
Media Contact: Marguerite Beck marbeck@wakehealth.edu
Media Office: 336-716-2415 Media Mobile: 336-480-8599
Patient Contact: Health On-Call® 1-800-446-2255

Glenn J. Lesser, MD

Professor of Internal Medicine - Hematology and Oncology
Director, Medical Neuro-Oncology

Lesser’s  clinical and research interests include the development of novel therapeutic agents for the treatment of adult malignant brain tumors and symptom management issues experienced by patients with cancer, including cancer-related pain, fatigue, nausea and vomiting, anemia, taste disturbances and anorexia/weight loss.

Recently, Lesser was awarded fellowship in the American College of Physicians. He also served as the elected medical oncology representative on the Society of Neuro-oncology's board of directors and as an appointed member of the American Society of Clinical Oncology's Scientific Program Committee.

Lesser has served as the principal investigator and lead author of phase I, II and III institutional and cooperative group neuro-oncology and symptom management clinical trials as well as a member of the research team/institutional principal investigator on well over 70 cooperative group and medical center clinical trials.

With his extensive neuro-oncologic clinical trials experience, in collaboration with Waldemar Debinski, M.D., Ph.D., Lesser aims to design effective molecularly targeted combinatorial therapies to improve treatment efficacy and survival in patients with high grade malignant primary brain tumors.

Keywords

Brain tumors, cancer pain, chemotherapy, experimental therapies

IN THE NEWS

Novel Brain Tumor Vaccine Acts Like Bloodhound to Locate Cancer Cells

A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.

Wake Forest Baptist Cancer Center Awarded $18 Million by National Cancer Institute
WFBMC has received an $18 million, five-year grant from the NCI’s Community Oncology Research Program to design and conduct community-based, clinical trials.
Wake Forest Baptist June Awards and Recognitions Vol II

Wake Forest Baptist Medical Center faculty, staff, programs and departments that have received awards or been recognized in the past month.

Related Experts

Waldemar Debinski, MD, PhD
Professor of Surgery - Neurosurgery
Area of Expertise: Cancer - Brain

Debinski, the director of the Brain Tumor Center of Excellence at Wake Forest Baptist, is a physician-scientist who pioneered a method to destroy malignant brain tumor cells without harming healthy cells. A drug developed by Debinski was an "unanticipated success" in early clinical trials


USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.